季度财报
Bone Biologics(BBLG)08-15 04:45
$Bone Biologics(BBLG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-011993 Act: 34 Size: 4 MB 网页链接
简介：Bone Biologics Corporation于2007年10月18日在特拉华州注册成立。该公司是一家医疗器械公司，目前专注于使用重组人蛋白质进行脊柱融合中的骨再生。该公司的平台技术已应用于脊柱、骨科、普通骨科、整形重建、神经外科、介入放射学和运动医学等外科专业领域并提供更好的结果。
| 今开：1.87 | 昨收：1.91 |
| 最高：1.88 | 最低：1.71 |
| 涨停价： | 跌停价： |
| 总市值：3141705 |
Bone Biologics(BBLG)08-15 04:45
$Bone Biologics(BBLG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-011993 Act: 34 Size: 4 MB 网页链接
Bone Biologics(BBLG)09-04 19:15
$Bone Biologics(BBLG)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-25-012604 Act: 34 Size: 294 KB 网页链接
Bone Biologics(BBLG)今天 06:25
$Bone Biologics(BBLG)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-107707 Act: 34 Size: 13 KB 网页链接
Bone Biologics(BBLG)08-29 22:35
$Bone Biologics(BBLG)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-012463 Act: 33 Size: 126 KB 网页链接
Bone Biologics(BBLG)09-03 18:15
$Bone Biologics(BBLG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002798 Act: 33 Size: 2 KB 网页链接
Bone Biologics(BBLG)09-27 05:05
$Bone Biologics(BBLG)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-25-015761 Act: 33 Size: 280 KB 网页链接
Bone Biologics(BBLG)09-27 05:05
$Bone Biologics(BBLG)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-25-015761 Act: 33 Size: 280 KB 网页链接查看全文
Bone Biologics(BBLG)09-04 19:15
$Bone Biologics(BBLG)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-25-012604 Act: 34 Size: 294 KB 网页链接查看全文
Bone Biologics(BBLG)09-03 18:15
$Bone Biologics(BBLG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002798 Act: 33 Size: 2 KB 网页链接查看全文
Bone Biologics(BBLG)08-29 22:35
$Bone Biologics(BBLG)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-25-012463 Act: 33 Size: 126 KB 网页链接查看全文
Bone Biologics(BBLG)08-15 04:45
$Bone Biologics(BBLG)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-25-011993 Act: 34 Size: 4 MB 网页链接查看全文
Bone Biologics(BBLG)07-04 05:35
$Bone Biologics(BBLG)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-25-061574 Act: 34 Size: 22 KB 网页链接查看全文
Bone Biologics(BBLG)07-01 04:45
$Bone Biologics(BBLG)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001641172-25-017165 Act: 34 Size: 1 MB 网页链接查看全文
Bone Biologics(BBLG)06-30 21:05
$Bone Biologics(BBLG)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001641172-25-017063 Act: 33 Size: 310 KB 网页链接查看全文
Bone Biologics(BBLG)06-30 18:05
$Bone Biologics(BBLG)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002071 Act: 33 Size: 2 KB 网页链接查看全文
Bone Biologics(BBLG)06-27 04:45
$Bone Biologics(BBLG)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001641172-25-016664 Act: 34 Size: 271 KB 网页链接查看全文
Bone Biologics(BBLG)在美国东部时间2月9日15:39:02停牌。 停牌原因编码：LUDP 停牌原因：涨跌幅波动异常交易暂停 恢复日期：2月9日 恢复报价时间：15:39:02 恢复交易时间：15:44:02 网页链接
来源：格隆汇 格隆汇6月15日丨Bone Biologics (BBLG.US)盘前跌47.07%，报2.08美元。Bone Biologics以每股1.97美元的价格公开发行254万股股票，总募集资金总额约为500万美元。 责任编辑：郭明煜 网页链接
$Bone Biologics(BBLG)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001213900-24-097239 Act: 34 Size: 48 KB 网页链接
$Bone Biologics(BBLG)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001493152-24-041710 Act: 34 Size: 436 KB 网页链接
$Bone Biologics(BBLG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-041658 Size: 8 KB 网页链接
$Bone Biologics(BBLG)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-24-041656 Size: 3 KB 网页链接
$Bone Biologics(BBLG)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001493152-24-038583 Act: 34 Size: 700 KB 网页链接
$Bone Biologics(BBLG)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-24-038575 Act: 33 Size: 740 KB 网页链接
$Bone Biologics(BBLG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-037218 Size: 11 KB 网页链接
$Bone Biologics(BBLG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-037222 Size: 10 KB 网页链接
$Bone Biologics(BBLG)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-037220 Size: 8 KB 网页链接
$Bone Biologics(BBLG)$ 8-K Current report, item 5.07 Accession Number: 0001493152-24-037146 Act: 34 Size: 273 KB 网页链接